SMLR semlerscientific.com: Multiplikator Forward P/S

Logo grafis Semler Scientific Corp (SMLR)

Semler Scientific, Inc. (SMLR) specializes in rapid diagnostics for vascular pathologies for US clinics. The forward P/S ratio on the GURU.Markets chart demonstrates market expectations, with the indicator level standing at 8.40. Risks are linked to a narrow product portfolio and insurance payouts, although the neutral geopolitical status of the biomedical industry provides stability.

semlerscientific.com - Rasio kapitalisasi marang dodolan sing dikarepake SMLR (periode 04.07.2022 - 31.01.2026)

Rincian metrik lan analitis perusahaan Semler (SMLR)

- data kapitalisasi saham perusahaan:
Ringkesan analitik perusahaan:Semler Scientific (SMLR)
Sampel barang Semler Scientific, Inc.

The forward P/S reflects the market valuation of each unit of expected revenue, allowing for a comparison between current market capitalization and projected sales volumes. The forward P/S trend for Semler Scientific, Inc. (SMLR) reveals the extent of asset overvaluation, which is becoming critical for Semler Scientific, Inc. (SMLR) due to the volatility of its Bitcoin strategy, which imposes financial risk on the stable vascular diagnostics business.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GE Healthcare Corp - Multiplikator Forward P/S|MTD (Mettler Toledo Inc) - Kapitalisasi marang prakiraan pendapatan|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Azenta Inc (AZTA)|Multiplikator Forward P/S VREX|Multiplikator Forward P/S Butterfly Corp (BFLY)|Rasio rega marang prakiraan pendapatan Mesa Laboratories, Inc. MLAB|quantum-si.com - Rasio rega marang prakiraan pendapatan|NNOX: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QTRX (Quanterix Corp.)|MASS: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep CapsoVision (CV)|Rasio rega marang prakiraan pendapatan MaxCyte, Inc.|RPID - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan SEER (Seer)|Multiplikator Forward P/S Hyperfine Inc (HYPR)|Multiplikator Forward P/S FONR (FONAR Corp)|Rasio kapitalisasi marang dodolan sing dikarepake Daxor Corp (DXR)|MDAI - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan VIVS|Aclarion, Inc. (ACON) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Talis Biomedical Corp TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)